What Nightstar Therapeutics plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Syncona Portfolio Ltd | 10% owner | Jun 07 | Disposition to Issuer · D | −13,203,922 | $25.50 | −$337M | 0 |
| Lubner David Charles | Director | Jun 07 | Disposition to Issuer · D | −29,124 | $25.50 | −$743K | 0 |
| Mott David M | Director | Jun 07 | Disposition to Issuer · D | −6,662,532 | $25.50 | −$170M | 0 |
| Fellows David A | Chief Executive Officer | Jun 07 | Disposition to Issuer · D | −617,090 | $25.50 | −$15.7M | 0 |
| New Enterprise Associates 15, L.p. | 10% owner | Jun 07 | Disposition to Issuer · D | −6,662,532 | $25.50 | −$170M | 0 |
| Ong Tuyen | Chief Development Officer | Jun 07 | Disposition to Issuer · D | −80,479 | $25.50 | −$2.05M | 0 |
| Hollowood Christopher J | Director | Jun 07 | Disposition to Issuer · D | −13,203,922 | $25.50 | −$337M | 0 |
| Whitcup Scott M | Director | Jun 07 | Disposition to Issuer · D | −74,568 | $25.50 | −$1.9M | 0 |
| McArthur James G | Director | Jun 07 | Disposition to Issuer · D | −37,237 | $25.50 | −$950K | 0 |
| Sundaram Senthil Vel | Chief Financial Officer | Jun 07 | Disposition to Issuer · D | −126,886 | $25.50 | −$3.24M | 0 |
| Robinson Gregory Scott | Chief Scientific Officer | Jun 07 | Disposition to Issuer · D | −103,182 | $25.50 | −$2.63M | 0 |
| Fellows David A | Chief Executive Officer | Apr 01 | Open-market sale · S | −9,305 | $25.31 | −$236K | 617,090 |
| Ong Tuyen | Chief Development Officer | Apr 01 | Open-market sale · S | −2,446 | $25.31 | −$61.9K | 80,479 |
| Sundaram Senthil Vel | Chief Financial Officer | Apr 01 | Open-market sale · S | −391 | $25.31 | −$9.9K | 126,886 |
| Robinson Gregory Scott | Chief Scientific Officer | Apr 01 | Open-market sale · S | −410 | $25.31 | −$10.4K | 103,182 |
| Fellows David A | Chief Executive Officer | Jan 07 | Sale for tax withholding · S | −8,733 | $12.98 | −$113K | 626,395 |
| Robinson Gregory Scott | Chief Scientific Officer | Jan 07 | Open-market sale · S | −425 | $19.98 | −$8.49K | 103,592 |
| Sundaram Senthil Vel | Chief Financial Officer | Jan 07 | Open-market sale · S | −406 | $12.98 | −$5.27K | 127,277 |
| Ong Tuyen | Chief Development Officer | Jan 07 | Open-market sale · S | −2,546 | $12.98 | −$33K | 82,925 |
| Ong Tuyen | Chief Development Officer | Jan 03 | Open-market sale · S | −4,070 | $12.00 | −$48.8K | 4,070 |
Loading...